Latanoprost: profile and news

Santen Announces Preliminary Results of Overseas Clinical Trials ... Feb 14, 2006
...in Tampere, Finland, Santen has conducted a European Phase III trial which was designed to confirm DE-085's non-inferiority to latanoprost ophthalmic solution ... - Genetic Engineering News,

Santen Pharmaceutical Announces Results of Overseas Clinical ... Feb 15, 2006
...demonstrated an eye pressure-lowering effect, but any favorable result was obtained from a non-inferiority study in which DE-085 was compared with latanoprost. ... - Japan Corporate News (press release),

Biovitrum enters trials for glaucoma drug Sep 13, 2005
...treatment of glaucoma. Latanoprost (xalatan), by Pfizer has in a short time become the golden standard for treatment. All drugs ... - Drug Researcher.com,

Red-tape reduction makes glaucoma medication easier to get Aug 3, 2005
From September 1 Pharmac will be removing the Special Authority from glaucoma eye drops bimatoprost, latanoprost and travoprost, and prescribing will instead ... - Stuff.co.nz

Easier access to glaucoma drops Aug 3, 2005
From 1 September PHARMAC will be removing the Special Authority from glaucoma eye drops bimatoporost, latanoprost and travoprost, and prescribing will instead ... - Scoop.co.nz (press release) <**results**>

Sami gets DCGI nod for phase III trials of Forskolin eye drops Jun 24, 2005
...main types of drugs used in the treatment of glaucoma-miotics, sympathomimetics, beta-blockers, carbonic anhydrase inhibitors, and latanoprost (Xalatan), a ... - Express Pharma Pulse,

University-Based Science and Biotechnology Products Defining the ... Feb 15, 2005
Columbia University licensed its patent on a novel way to treat glaucoma to Pharmacia, which eventually developed the blockbuster drug latanoprost, earning the ... - Journal of American Medical Association (subscription),